Certain Ordinary Shares of TheraVet SA are subject to a Lock-Up Agreement Ending on 14-DEC-2021. These Ordinary Shares will be under lockup for 184 days starting from 13-JUN-2021 to 14-DEC-2021. Details: The Company has undertaken to SwissLife Banque Privée not to issue, offer or the assignment, nor to agree to a promise of assignment, in a direct or indirect form (in particular in the form of derivative transactions with shares as underlying), shares or securities, giving rights by conversion, exchange, redemption, presentation of a voucher or in any other way to the allocation of securities issued or to be issued in representation of a portion of the Company's capital, nor to publicly formulate the intention to carry out one or more of the operations listed above in this paragraph, until the expiration of a period of 180 calendar days following the date of delivery of the shares issued under the Offer, except prior written consent of SwissLife Banque Privée notified to the Company; it being specified that (i) the issue of shares issued under the Offer, (ii) securities likely to be issued, offered or sold to employees or corporate officers, including future programs (warrants), authorized on the date hereof by the general meeting of the Company, (iii) any transaction carried out in the under a share buyback program in accordance with legal and regulatory provisions as well as the applicable market rules, (iv) the Company's securities issued as part of a merger or an acquisition of the securities or assets of another entity, provided that the beneficiary of these securities agree to take over this commitment for the remaining period of this commitment and to the condition that the total number of Company shares issued in this context does not exceed 3% of the capital, are excluded from the scope of this abstention commitment. Mr. Enrico Bastianelli directly holding 23.52% of the capital and voting rights on the date of the Information Document may not sell the shares held for a period of 12 months from the date of issue of the Shares and the other shareholders of the Company holding together 76.48% of the capital and voting rights on the date of publication of the Information Document will not be able to sell the shares they hold for a period of 6 months from the date issue of the New Shares issued under the Offer except with the prior agreement of the Listing Sponsor.